Vimarsana
Biggest News Aggregation in the World

Page 20 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Optina's Landmark REPHRASE Study to Validate an Innovative Cerebral Amyloid Status Test for the Diagnosis and Management of Alzheimer's Disease - Vimarsana News

Optina's Landmark REPHRASE Study to Validate an Innovative Cerebral Amyloid Status Test for the Diagnosis and Management of Alzheimer's Disease

/PRNewswire/ -- Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of...

A Pathway for Medicare Coverage for Breakthrough Devices: Take Two | King & Spalding - Vimarsana News

A Pathway for Medicare Coverage for Breakthrough Devices: Take Two | King & Spalding

On June 27, 2023, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a “Notice with Comment Period” (“Notice”) describing a new process for providing expedited...

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors - Vimarsana News

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors - Vimarsana News

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

SAN DIEGO, July 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced...

FDA Grants De Novo Marketing Authorization for - Vimarsana News

FDA Grants De Novo Marketing Authorization for

Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the Leading Cause of...